AI model predicts death, complications for patients undergoing angioplasty, stents

It showed high levels of accuracy at predicting death, major bleeding events and the need for blood transfusion

5:00 AM

Author | Noah Fromson

doctor heart floating stethoscope
Getty Images

Listen to this article on Health Lab's podcast.

When a person has one or more blocked arteries, providers may choose to conduct a minimally invasive procedure known as percutaneous coronary intervention, or PCI. 

By inflating a balloon and potentially placing a stent, blood can flow more freely from the heart. 

Despite carrying less risk than open surgery, stenting and balloon angioplasty can result in complications like bleeding and kidney injury. 

Researchers at Michigan Medicine developed an AI-driven algorithm that accurately predicts death and complications after PCI — which could emerge as a tool for clinicians as they determine treatment for blocked heart arteries.

The results are published in European Heart Journal.

“The risks for patients undergoing percutaneous coronary intervention vary greatly depending on the individual patient, and both patients and clinicians have historically both over and underestimated the harms associated with PCI,” said lead David E. Hamilton, M.D., a cardiology-critical care fellow at Michigan Medicine. 

“Precise risk prediction is critical to treatment selection and the shared decision-making process. Our tool can recognize a wide array of outcomes after PCI and can be used by care providers and patients together to decide the best course of treatment.”

While other risk stratification tools have been created to identify risk after PCI, researcher say, many have modest accuracy and were made without involving a key party: patients. 

The Michigan Medicine team collected data from all adult patients who underwent PCI between April 2018 and the end of 2021 using the Blue Cross Blue Shield of Michigan Cardiovascular Consortium, or BMC2, registry. 

The consortium is comprised of hospitals across the state of Michigan that use data they collect to inform quality projects, and improve care and patient outcomes.

Researchers used that data — including more than 20 pre-procedural characteristics, such as age, blood pressure and total cholesterol — to create a risk prediction model with the machine learning software “XGBoost”.

The AI-driven model showed high levels of accuracy at predicting death, major bleeding events and the need for blood transfusion. It outperformed other models that used the same pre-procedural characteristics.

“We combined the predictive model with patient feedback from the PCI Patient Advisory Council to transform machine learning into this patient-centered, individualized risk prediction tool,” said senior author Hitinder Gurm, MBBS, interim chief medical officer at U-M Health.  

“In the age of widespread smartphones and electronic medical records, this computerized risk score could be integrated into electronic health systems  and made easy to use at the bedside. It would not only help relay complex information to the provider quickly, but it could also be used to enhance patient education on the risks related to PCI.”

The innovative technology has been harnessed into a computer and phone application to allow for free and widespread use.

Jeremy Albright Ph.D., Milan Seth, Devraj Sukul M.Sc., M.D., all of Michigan Medicine, Ian Painter Ph.D., of Washington State Department of Health and Foundations for Health Care Quality, Charles Maynard Ph.D., of Foundations for Health Care Quality and University of Washington, and Ravi S. Hira M.D., of University of Washington and Pulse Heart Institute and Multicare Health System. 

Support for BMC2 is provided by Blue Cross and Blue Shield of Michigan and Blue Care Network as part of the BCBSM Value Partnerships program. Although Blue Cross Blue Shield of Michigan and BMC2 work collaboratively, the opinions, beliefs and viewpoints expressed by the author do not necessarily reflect the opinions, beliefs, and viewpoints of BCBSM or any of its employees.

Paper cited: “Merging Machine Learning and Patient Preference: Patient-Centered Tool for Predicting Risk of Percutaneous Coronary Intervention,” European Heart Journal. DOI: 10.1093/eurheartj/ehad836

Sign up for Health Lab newsletters today. Get medical tips from top experts and learn about new scientific discoveries every week by subscribing to Health Lab’s two newsletters, Health & Wellness and Research & Innovation.

Sign up for the Health Lab Podcast: Add us on Spotify, Apple Podcasts or wherever you get you listen to your favorite shows.


More Articles About:

Interventional cardiology Heart Attack Treatment Heart Attack Risk Factors Cardiovascular: Diagnostics & Procedures Cardiovascular: Diseases & Conditions Cardiovascular: Treatment & Surgery Emerging Technologies Hospitals & Centers
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Related

kidneys blue yellow
Health Lab

Algorithm predicts females have higher risk for kidney damage after aneurysm repair

For an abdominal aortic aneurysm, female patients have a higher risk for kidney damage after endovascular repair, a Michigan Medicine study finds.

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Three people in a bar watch a television displaying a sports logo and a person smiling. Shelves with bottles and a counter with glasses are visible.
Health Lab

Jalen Hurts’ blood clot diagnosis: doctors answer common questions

After Jalen Hurts’ blood clot diagnosis, Michigan Medicine experts explain clot risks, treatment and returning safely to sports.
A pill bottle is open and pills are placed onto a hand
Health Lab

Could a diabetes medication be the next wonder drug?

Researchers identified how sotagliflozin may reduce heart attack and stroke risk, potentially offering benefits beyond diabetes care
Gene editing, conceptual illustration. DNA (deoxyribonucleic acid) double helix under a magnifying glass
Health Lab

Gene editing is coming for common diseases. Are we ready?

Gene therapies may offer one-time treatment for disease, but experts say safety, reversibility, cost and long-term monitoring must guide use.
Purple shaded illustration of doctor listening to heart of patient on a bed
Health Lab

The AI is listening: Implications of machine generated clinical notes on health care

Michigan Medicine experts argue that use of artificial intelligent scribes during health care visits should be more carefully examined .
Catheterized hospital patient's leg
Health Lab

Many hospitals still don’t do enough to prevent UTIs from catheters

Urinary catheters used by hospitals can lead to UTIs, bladder infections and bloodstream infections, yet hospital infection prevention efforts lag even after 20 years of effort.
Two people in medical scrubs are in a blurred hospital setting. In the foreground, hands are holding a digital tablet.
Health Lab

Digital alerts support timely treatment decisions of critically ill cardiac patients

Well-designed alerts for critically ill cardiac patients can change what happens at the bedside, according to new Michigan Medicine research.